Recent News
Chiesi Announces FDA Acceptance of New Drug Application for its Triple...
Asthma remains a significant health burden in the U.S., with more than 60% of adults continuing to experience frequent symptoms despite the availability of many treatments.1Chiesi’s single inhaler triple therapy (beclomethasone...